These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 19076893

  • 1. Delayed-type hypersensitivity to heparins: different patterns of cross-reactivity.
    Palacios Colom L, Alcántara Villar M, Luis Anguita Carazo J, Ruiz Villaverde R, Quiralte Enríquez J.
    Contact Dermatitis; 2008 Dec; 59(6):375-7. PubMed ID: 19076893
    [No Abstract] [Full Text] [Related]

  • 2. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
    Gaigl Z, Pfeuffer P, Raith P, Bröcker EB, Trautmann A.
    Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
    [Abstract] [Full Text] [Related]

  • 3. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight.
    Grims RH, Weger W, Reiter H, Arbab E, Kränke B, Aberer W.
    Br J Dermatol; 2007 Sep; 157(3):514-7. PubMed ID: 17573880
    [Abstract] [Full Text] [Related]

  • 4. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases.
    Jappe U, Juschka U, Kuner N, Hausen BM, Krohn K.
    Contact Dermatitis; 2004 Aug; 51(2):67-72. PubMed ID: 15373846
    [Abstract] [Full Text] [Related]

  • 5. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
    Irion R, Gall H, Peter RU.
    Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948
    [No Abstract] [Full Text] [Related]

  • 6. Unexpected delayed-type hypersensitivity skin reactions to the ultra-low-molecular-weight heparin fondaparinux.
    Maetzke J, Hinrichs R, Schneider LA, Scharffetter-Kochanek K.
    Allergy; 2005 Mar; 60(3):413-5. PubMed ID: 15679737
    [No Abstract] [Full Text] [Related]

  • 7. Delayed hypersensitivity challenged by subcutaneous Bemiparin.
    Moreno Escobosa MC, Moya Quesada MC, Granados SC, Amat López J.
    Allergol Immunopathol (Madr); 2011 Mar; 39(5):309-10. PubMed ID: 21129837
    [No Abstract] [Full Text] [Related]

  • 8. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids.
    Schiffner R, Glässl A, Landthaler M, Stolz W.
    Contact Dermatitis; 2000 Jan; 42(1):49. PubMed ID: 10644031
    [No Abstract] [Full Text] [Related]

  • 9. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight. Commentary.
    Gómez-Outes A, Gómez de la Bárcena C, Martínez-González J.
    Br J Dermatol; 2008 Apr; 158(4):869-70. PubMed ID: 18284394
    [No Abstract] [Full Text] [Related]

  • 10. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
    Ludwig RJ, Schindewolf M, Alban S, Kaufmann R, Lindhoff-Last E, Boehncke WH.
    Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404
    [Abstract] [Full Text] [Related]

  • 11. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
    Koch P.
    Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
    [Abstract] [Full Text] [Related]

  • 12. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update.
    Jappe U.
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):605-13. PubMed ID: 17102645
    [Abstract] [Full Text] [Related]

  • 13. The influence of heparin's molecular weight and the incidence of delayed type hypersensitivity reactions revisited; in response to Grims et al., Br J Dermatol 2007; 157:514-17.
    Ludwig RJ, Schindewolf M, Lindhoff-Last E, Boehncke WH.
    Br J Dermatol; 2008 Apr; 158(4):849-51. PubMed ID: 18205866
    [No Abstract] [Full Text] [Related]

  • 14. [A study of 19 cases of allergy to heparins with positive skin testing].
    Phan C, Vial-Dupuy A, Autegarden JE, Amsler E, Gaouar H, Abuaf N, Pecquet C, Francès C, Soria A.
    Ann Dermatol Venereol; 2014 Jan; 141(1):23-9. PubMed ID: 24461090
    [Abstract] [Full Text] [Related]

  • 15. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins.
    Lopez S, Torres MJ, Rodríguez-Pena R, Blanca-Lopez N, Fernandez TD, Antunez C, Canto G, de Luque V, Mayorga C.
    Br J Dermatol; 2009 Feb; 160(2):259-65. PubMed ID: 18945304
    [Abstract] [Full Text] [Related]

  • 16. Immediate type hypersensitivity to low molecular weight heparins and tolerance of unfractioned heparin and fondaparinux.
    Harr T, Scherer K, Tsakiris DA, Bircher AJ.
    Allergy; 2006 Jun; 61(6):787-8. PubMed ID: 16677252
    [No Abstract] [Full Text] [Related]

  • 17. [Diagnosis of drug-related immunologic cutaneous reactions].
    Borch JE, Bindslev-Jensen C.
    Ugeskr Laeger; 2005 Feb 07; 167(6):631-6. PubMed ID: 15771376
    [No Abstract] [Full Text] [Related]

  • 18. Possible anergy after generalized orally elicited allergic contact dermatitis to corticosteroid.
    Thong HY, Yokota M, Chan H, Maibach HI.
    Contact Dermatitis; 2008 Feb 07; 58(2):126-8. PubMed ID: 18186763
    [No Abstract] [Full Text] [Related]

  • 19. Heparin-induced skin necrosis and low molecular weight heparins.
    Drew PJ, Smith MJ, Milling MA.
    Ann R Coll Surg Engl; 1999 Jul 07; 81(4):266-9. PubMed ID: 10615196
    [Abstract] [Full Text] [Related]

  • 20. Skin reactions due to low molecular weight heparin in pregnancy: a strategic dilemma.
    Verdonkschot AE, Vasmel WL, Middeldorp S, van der Schoot JT.
    Arch Gynecol Obstet; 2005 Feb 07; 271(2):163-5. PubMed ID: 15112083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.